Cardiogenic pulmonary oedema: presentation of pre-eclampsia exacerbated by prostaglandin abortifacients.
Levy
D M
DM
Department of Anaesthetics, Aberdeen Maternity Hospital, UK.
Hinshaw
K
K
Knox
F M
FM
Campbell
D M
DM
Sutherland
H W
HW
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000293:Adolescent; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D003422:Critical Care; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011225:Pre-Eclampsia / Q000150:complications*; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000009:adverse effects*; D011654:Pulmonary Edema / Q000209:etiology* / Q000628:therapy
D000020:Abortifacient Agents, Nonsteroidal; D011459:Prostaglandins E, Synthetic; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil